BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Mar 30, 2018
Clinical News

Biosimilars, Clovis' Rubraca among CHMP recommendations

Read More
BioCentury | Dec 8, 2017
Clinical News

FDA extends Amgen's Repatha approval to prevent CV events

Read More
BioCentury | Aug 16, 2017
Clinical News

Amgen sBLA gets Priority Review for Repatha CVOT data

Read More
BioCentury | Jun 9, 2017
Clinical News

Amgen submits US/EU regulatory applications for Repatha CVOT data

Read More
BioCentury | Mar 24, 2017
Clinical News

Repatha: Additional Ph III FOURIER data

Read More
BioCentury | Mar 17, 2017
Clinical News

Repatha: Ph III data

Read More
BioCentury | Feb 10, 2017
Clinical News

Repatha: Ph III FOURIER data

Read More
BioCentury | Feb 10, 2017
Clinical News

Repatha: Ph III EBBINGHAUS data

Read More
BioCentury | Nov 18, 2016
Clinical News

Repatha: Additional Ph III GLAGOV data

Read More
BioCentury | Oct 10, 2016
Clinical News

Repatha evolocumab: Phase III data

Read More
Items per page:
1 - 10 of 99